Вторник, 07.04.2020, 23:09
Главная Регистрация Вход
Приветствую Вас, Гость · RSS
Каталог товаров

Меню сайта
Другие города

Добавить объявления 

В других городах Украины

Добавить в АР Крым

Добавить в Киев

Добавить в Харьков

Добавить в Одессу

Добавить в Днепропетровск

Добавить в Донецк

Добавить в Запорожье

Добавить во Львов

Добавить в Кривой Рог

Добавить в Николаев

Добавить в Мариуполь

Добавить в Луганск

Добавить в Севастополь

Добавить в Винница

Добавить в Макеевка

Добавить в Симферополь

Добавить в Херсон

Добавить в Полтава

Добавить в Чернигов

Добавить в Черкассы

Добавить в Житомир

Добавить в Сумы

Добавить в Хмельницкий

Добавить в Горловка


Онлайн всего: 2
Гостей: 2
Пользователей: 0
Форма входа
Друзья сайта
  • Объявления Днепропетровск
  • Объявления Одесса
  • Объявления Харьков
  • Объявления Донецк
  • Объявления Киев
  • Объявления Кривой рог
  • Объявления Запорожье
  • Объявления Мариуполь
  • Объявления Николаев
  • Объявления Львов
  • Объявления Крым
  • куплю шины шины Днепропетровск купить шины Киев
  •  Доска объявлений Одесса
    Главная » Доска объявлений » Услуги в разных сферах Одесса » Страхование Одесса

    Mikhail V. Blagosklonny
    Предложение | 15.10.2019, 18:24

    Mikhail V. Blagosklonny graduated with an MD and PhD from First Pavlov State Medical
    University of St. Petersburg, RUS. Dr. Mikhail V. Blagosklonny has then
    Moved to the United States, where he was
    Awarded the prestigious Fogarty Fellowship from the National Institutes of Health.
    During his fellowship in Leonard Neckers’ lab at the National
    Cancer Institute (NCI), he was a co-author of 18 publications on
    Different biomedical themes, like targeting
    HSP90, p53, Bcl2, Erb2, and Raf-1. He also was the last writer on a clinical phase I/II
    Trial publication.
    After authoring seven papers during a brief yet productive
    Senior research fellowship in the El-Deiry Cancer Research Lab at the University of Pennsylvania,
    Dr. Blagosklonny returned to NCI to team up with Tito Fojo. Together, they
    Published 26 papers. In addition, Dr. Mikhail Blagosklonny published many of experimental research papers and theoretical articles as sole
    Author. Those sole-author papers
    Discussed two important topics.
    The first of these discussed selectively killing cancer
    Cells with deregulated cell cycle or drug resistance via
    Validation their resistance. The results and underlying
    Concept were so revolutionary that they were improperly cited by
    Other scientists as “reversal of resistance, ” even though the paper was
    Named, “Exploiting of drug resistance instead of its reversal. ” One great
    Supporter of this concept was the world-famous scientist Arthur Pardee, with whom Dr.
    Blagosklonny co-authored a joint publication in 2001.
    The second topic throughout Dr. Blagosklonny’s sole-author works
    Is a research methodology to come up with knowledge by
    Bringing a few facts together from seemingly unrelated fields.
    This results in new concepts containing testable forecasts, which in
    Turn can be “tested” by analyzing the literature further. Once again, the
    Concept was co-authored by Arthur Pardee in a 2002 article in Nature. The
    First success of the new research method was the description of the feedback
    Regulation of p53, as confirmed by the discovery of mdm2/p53 loop; and the
    Explanation why mutant p53 is always overexpressed, published in 1997. The most
    Important outcome discovered by Dr.
    Blagosklonny’s research methods is the hyperfunction (or quasi-programmed)
    Theory of aging and the revelation of rapamycin as an exclusively well-tolerated
    Anti-aging drug, published in 2006. As mentioned in Scientific American,
    Michael Hall, who discovered mTOR in 1991, gives Dr. Blagosklonny recognition for
    “connecting dots that others can’t even see. ”
    In 2002, Dr. Blagosklonny became associate professor of medicine at New York Medical College.
    He agreed to accept responsibilities as a senior scientist at Ordway
    Research Institute in Albany, New York, in 2005, prior to accepting another
    Position at Roswell Park Cancer Institute as professor of oncology in 2009.
    Since joining Roswell Park Comprehensive Cancer Center in 2009, Dr. Blagosklonny
    Has studied the prevention of cancer (an age-related disease) via
    Preventing organism aging — in other words, “preventing cancer
    By staying young. ” His lab closely worked together with
    Andrei Gudkov’s and completed research on the suppression of
    Cellular senescence, namely suppression of cellular conversion from healthy quiescence to
    Permanent senescence. This led to the discovery of additional anti-aging
    Medications beyond rapamycin. The cell culture studies were
    Complemented by studies in mice, including several models like
    Standard and aging mice, p53-deficient mice, and mice on a high-fat diet.
    Dr. Mikhail Blagosklonny has also published extensively on the prevention of cellular
    Senescence by rapamycin as well as other mTOR inhibitors, life
    Extension and cancer stoppage in mice, and combinations of anti-
    Aging drugs to be taken by humans. A
    Rapamycin-based combination of seven clinically available drugs has
    Been named the “Koschei Formula” and is now utilized for the treatment of aging in patients
    At the Alan Green Clinic in Little Neck, New York.


    Добавил: greenvikzal |
    Просмотров: 56 | Рейтинг: 0.0/0
    Всего комментариев: 0
    Имя *:
    Email *:
    Код *:
    Copyright MyCorp © 2020
    Газовые котлы в Днепре
    Новости Одессы
    Бесплатный хостинг uCoz
    Одесса объявления, это то что больше всего интересует бизнес сообщество нашего города, бесплатные объявления Одесса вы всегда сможете разместить на нашем сайте так как это не простая доска объявлений Одесса а самая настоящая онлайн газета объявлений и здесь есть одесса частные объявления